Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
Go back to Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 1.72 -0.07 (3.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.79 | 52 Week High | $19.41 | |||
| Open | $1.77 | 52 Week Low | $4.83 | |||
| Day High | $1.79 | P/E | N/A | |||
| Day Low | $1.70 | EPS | $-2.74 | |||
| Volume | 1,007,322 | |||||
